ETON
Eton Pharmaceuticals Inc
NASDAQ: ETON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$24.12
+2.29% today
Updated 2026-04-30
Market cap
$628.09M
P/E ratio
—
P/S ratio
7.86x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$13 – $27
Volume
0.4M
Eton Pharmaceuticals Inc (ETON) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $959000.00 | $39000.00 | $21.83M | $21.25M | $31.64M | $39.01M | $79.95M |
| Revenue growth (YoY) | — | — | — | -95.9% | +55879.5% | -2.7% | +48.9% | +23.3% | +104.9% |
| Cost of revenue | $13000.00 | $63000.00 | $453000.00 | $286000.00 | $2.62M | $6.93M | $10.58M | $15.60M | $37.21M |
| Gross profit | $-13000.00 | $-63000.00 | $506000.00 | $-247000.00 | $19.21M | $14.32M | $21.06M | $23.41M | $42.74M |
| Gross margin | — | — | 52.8% | -633.3% | 88.0% | 67.4% | 66.6% | 60.0% | 53.5% |
| R&D | $3.93M | $5.63M | $11.55M | $14.10M | $6.24M | $4.00M | $3.32M | $3.25M | $7.76M |
| SG&A | $4.83M | $4.69M | $7.55M | $12.76M | $14.47M | $18.58M | $18.93M | $22.75M | $35.82M |
| Operating income | $-7.15M | $-10.32M | $-18.60M | $-27.11M | $-1.50M | $-8.26M | $-1.19M | $-2.60M | $72000.00 |
| Operating margin | — | — | -1939.6% | -69515.4% | -6.8% | -38.9% | -3.8% | -6.7% | 0.1% |
| EBITDA | $-7.14M | $-10.26M | $-18.15M | $-26.46M | $-1.03M | $-6.49M | $-291000.00 | $-1.45M | $4.12M |
| EBITDA margin | — | — | -1893.0% | -67846.2% | -4.7% | -30.5% | -0.9% | -3.7% | 5.1% |
| EBIT | $-7.16M | $-10.32M | $-18.60M | $-27.11M | $-1.50M | $-8.26M | $-1.19M | $-2.60M | $72000.00 |
| Interest expense | $0.00 | $164000.00 | $281000.00 | $889000.00 | $1.01M | $955000.00 | $1.06M | $2.00M | $4.78M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-7.16M | $-12.74M | $-18.32M | $-27.97M | $-1.96M | $-9.02M | $-936000.00 | $-3.82M | $-4.60M |
| Net income growth (YoY) | — | -78.0% | -43.8% | -52.7% | +93.0% | -361.4% | +89.6% | -308.4% | -20.4% |
| Profit margin | — | — | -1910.3% | -71717.9% | -9.0% | -42.4% | -3.0% | -9.8% | -5.8% |